Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
82.81
-2.34 (-2.75%)
At close: Sep 12, 2025, 4:00 PM EDT
83.17
+0.36 (0.43%)
After-hours: Sep 12, 2025, 7:59 PM EDT
Merck & Co. Employees
As of December 31, 2024, Merck & Co. had 75,000 total employees, including 73,000 full-time and 2,000 part-time employees. The number of employees increased by 3,000 or 4.17% compared to the previous year.
Employees
75,000
Change (1Y)
3,000
Growth (1Y)
4.17%
Revenue / Employee
$848,213
Profits / Employee
$218,747
Market Cap
206.84B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 75,000 | 3,000 | 4.17% |
Dec 31, 2023 | 72,000 | 3,000 | 4.35% |
Dec 31, 2022 | 69,000 | 1,000 | 1.47% |
Dec 31, 2021 | 68,000 | -6,000 | -8.11% |
Dec 31, 2020 | 74,000 | 3,000 | 4.23% |
Dec 31, 2019 | 71,000 | 2,000 | 2.90% |
Dec 31, 2018 | 69,000 | 0 | - |
Dec 31, 2017 | 69,000 | 1,000 | 1.47% |
Dec 31, 2016 | 68,000 | 0 | - |
Dec 31, 2015 | 68,000 | -2,000 | -2.86% |
Dec 31, 2014 | 70,000 | -6,000 | -7.89% |
Dec 31, 2013 | 76,000 | -7,000 | -8.43% |
Dec 31, 2012 | 83,000 | -3,000 | -3.49% |
Dec 31, 2011 | 86,000 | -8,000 | -8.51% |
Dec 31, 2010 | 94,000 | -6,000 | -6.00% |
Dec 31, 2009 | 100,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
AbbVie | 55,000 |
MRK News
- 2 days ago - Merck's pneumonia shot shows promise in late-stage study - Reuters
- 2 days ago - CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Children and Adolescents at Increased Risk of Pneumococcal Disease - Business Wire
- 2 days ago - Britain defends investment record as Merck scraps labs over pharma environment - Reuters
- 3 days ago - US drugmaker Merck scraps £1bn London research centre and cuts 125 science jobs - The Guardian
- 3 days ago - US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says - Reuters
- 3 days ago - Merck to scrap London drug research centre - Reuters
- 4 days ago - US FDA to step up enforcement of pharma ads, sends enforcement letters - Reuters
- 5 days ago - Merck & Co., Inc. (MRK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha